Toronto Dominion Bank
PRAX icon

Toronto Dominion Bank’s Praxis Precision Medicines PRAX Stock Holding History

Toronto Dominion Bank’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.1K Sell
90
-199
-69% -$63K ﹤0.01% 1976
2026
Q1 		$93.1K Buy
+289
New +$89.4K ﹤0.01% 1691
2025
Q3 		– Sell
-3,100
Closed -$130K – 2061
2025
Q2 		$130K Buy
+3,100
New +$118K ﹤0.01% 1345
2023
Q4 		– Sell
-27
Closed -$684 – 1748
2023
Q3 		$684 Hold
27
– – ﹤0.01% 1469
2023
Q2 		$0 Buy
+27
New +$413 ﹤0.01% 1728

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Toronto Dominion Bank's PRAX Position: Q2 2026 in Review

Toronto Dominion Bank reduced its Praxis Precision Medicines (PRAX) stake by 69% in Q2 2026, selling an estimated $63K and leaving 90 shares worth $30.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1976.

Toronto Dominion Bank first reported a position in PRAX in Q2 2023 and has held it in 5 quarters since. The position peaked at $130K in Q2 2025. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Toronto Dominion Bank held 90 shares of Praxis Precision Medicines worth $30.1K as of Q2 2026.
  • Toronto Dominion Bank sold 199 Praxis Precision Medicines shares in Q2 2026, an estimated $63K.
  • Praxis Precision Medicines made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #1976 holding.
  • Toronto Dominion Bank first reported a position in Praxis Precision Medicines in Q2 2023 and has held it in 5 quarters since.
  • Toronto Dominion Bank's Praxis Precision Medicines position peaked at $130K in Q2 2025.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.